Valuation: AtriCure, Inc.

Market Cap 1.77B 1.56B 1.45B 1.34B 2.51B 170B 2.54B 17.25B 6.74B 84.01B 6.66B 6.52B 291B P/E 2026 *
354x
P/E 2027 * 89.4x
Enterprise Value 1.62B 1.42B 1.33B 1.22B 2.29B 155B 2.32B 15.75B 6.15B 76.67B 6.08B 5.95B 265B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.27x
Free-Float
96.14%
Yield 2026 *
-
Yield 2027 * -
1 day+6.65%
1 week+6.92%
Current month+33.56%
1 month+23.82%
3 months+27.63%
6 months-2.96%
Current year-5.54%
1 week 31.9
Extreme 31.895
37.44
1 month 27.24
Extreme 27.24
37.44
Current year 25.36
Extreme 25.36
43.18
1 year 25.36
Extreme 25.36
43.18
3 years 18.94
Extreme 18.94
57.77
5 years 18.94
Extreme 18.94
89.18
10 years 13.45
Extreme 13.45
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 54 01/03/2017
Director TitleAgeSince
Director/Board Member 62 04/12/2019
Director/Board Member 55 02/11/2012
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap.
30/6/26 Free

Chief Executive Officer

636 0.0013%
30/6/26 Free

General Counsel

636 0.0013%
30/6/26 Free

Chief Technology Officer

636 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+6.65%+6.92%+18.63%-35.27% 1.77B
+1.39%+3.78%-17.43%-8.41% 180B
+1.21%+1.23%-9.38%-6.84% 107B
+0.41%+1.06%+7.16%+65.76% 60.29B
+0.67%-1.94%+27.88%+55.85% 50.19B
+1.64%+0.47%-14.25%-43.80% 43.08B
+2.45%-0.23% - - 32.77B
+2.56%-4.28%-17.55%-43.86% 27.61B
+0.93%-7.53%+25.71%-12.70% 23.1B
+2.02%+0.26%-5.23%-5.81% 20.86B
Average +1.99%-1.99%+1.73%-3.90% 54.57B
Weighted average by Cap. +1.34%-0.39%-5.61%+1.86%

Financials

2026 *2027 *
Net sales 606M 533M 496M 456M 856M 58.13B 867M 5.89B 2.3B 28.69B 2.28B 2.23B 99.24B 679M 597M 556M 511M 959M 65.14B 972M 6.6B 2.58B 32.16B 2.55B 2.49B 111B
Net income 6.32M 5.56M 5.18M 4.76M 8.93M 606M 9.05M 61.45M 24.01M 299M 23.73M 23.21M 1.03B 20.68M 18.19M 16.94M 15.57M 29.21M 1.98B 29.61M 201M 78.56M 979M 77.65M 75.97M 3.39B
Net Debt -155M -136M -127M -117M -219M -14.86B -222M -1.51B -589M -7.34B -582M -569M -25.38B -232M -204M -190M -175M -328M -22.28B -333M -2.26B -882M -11B -872M -853M -38.04B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
27/07/26 USD 37.37 +6.65% 1,189,257
24/07/26 USD 35.04 +6.18% 1,655,002
23/07/26 USD 33.00 -1.55% 1,137,045
22/07/26 USD 33.52 -2.85% 713,208
21/07/26 USD 34.51 -0.76% 671,902
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
35.04USD
Average target price
47.00USD
Spread / Average Target
+34.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock